- €8.33bn
- €17.91bn
- €1.42bn
- 51
- 63
- 96
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,523 | 1,304 | 1,250 | 1,429 | 1,420 |
Cost of Revenue | |||||
Gross Profit | 1,131 | 846 | 880 | 1,035 | 1,034 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 998 | 2,116 | 960 | 873 | 963 |
Operating Profit | 525 | -812 | 290 | 555 | 457 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 396 | -1,003 | 259 | 501 | 275 |
Provision for Income Taxes | |||||
Net Income After Taxes | 372 | -931 | 572 | 430 | 174 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 325 | -786 | 545 | 415 | 193 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 325 | -786 | 545 | 415 | 193 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.15 | -2.72 | 2.15 | 1.45 | 0.705 |
Dividends per Share | |||||
Special Dividends per Share |